Improving Cancer Outcomes and Fairness for All
Cancer Control Program
This program works to understand and address the many factors that influence cancer, aiming to improve health and ensure fair outcomes for everyone.
Quick facts
| Grant type | P30 center grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11099768 on NIH RePORTER |
What this research studies
Our program uses a team approach to understand how social and structural factors affect cancer, from biological mechanisms to community-level influences. We develop and put into practice effective behavioral, clinical, and policy solutions to reduce the burden of cancer. This includes looking at risk factors like tobacco use and physical activity, improving cancer screening, and ensuring better care for diverse populations. Ultimately, we aim to translate this knowledge into programs and policies that create more equitable cancer health outcomes.
Who could benefit from this research
Good fit: This program is relevant for individuals and communities affected by cancer, particularly those from diverse populations or who experience health disparities.
Not a fit: Patients seeking direct individual medical treatment for an active cancer diagnosis may not directly benefit from this population-focused program.
Why it matters
Potential benefit: If successful, this program could lead to improved cancer health outcomes and greater fairness in cancer care for communities, especially those that are often underserved.
How similar studies have performed: Cancer control programs often build on established public health and behavioral science principles, with this program applying a comprehensive, multi-disciplinary approach to structural and social determinants.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Ling, Pamela May — University of California, San Francisco
- Study coordinator: Ling, Pamela May
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.